Sergio Coffa

Array ( [id] => 7490158 [patent_doc_number] => 20110237524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'POLYMER CONJUGATES OF AOD-LIKE PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/119256 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28157 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237524.pdf [firstpage_image] =>[orig_patent_app_number] => 13119256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6187673 [patent_doc_number] => 20110171165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'POLYMER CONJUGATES OF OPIOID GROWTH FACTOR PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/119281 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 32359 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171165.pdf [firstpage_image] =>[orig_patent_app_number] => 13119281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102570 [patent_doc_number] => 20110166063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'POLYMER CONJUGATES OF THERAPEUTIC PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/119297 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 85 [patent_figures_cnt] => 85 [patent_no_of_words] => 128059 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166063.pdf [firstpage_image] =>[orig_patent_app_number] => 13119297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490063 [patent_doc_number] => 20110237496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'ANTINECROTIC ACTIVITY OF ALPHA 1-ANTITRYPSIN' [patent_app_type] => utility [patent_app_number] => 13/063202 [patent_app_country] => US [patent_app_date] => 2009-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12959 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237496.pdf [firstpage_image] =>[orig_patent_app_number] => 13063202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064152 [patent_doc_number] => 20110201546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'METHODS OF TREATMENT USING SINGLE DOSES OF ORITAVANCIN' [patent_app_type] => utility [patent_app_number] => 13/060811 [patent_app_country] => US [patent_app_date] => 2009-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14857 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201546.pdf [firstpage_image] =>[orig_patent_app_number] => 13060811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6477406 [patent_doc_number] => 20100041587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'COMBINATION THERAPY FOR INHIBITION OF PLATELET AGGREGATION' [patent_app_type] => utility [patent_app_number] => 12/540062 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10041 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041587.pdf [firstpage_image] =>[orig_patent_app_number] => 12540062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177463 [patent_doc_number] => 20110178027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'Multi-LEU Peptides and Analogues Thereof as Selective PACE4 Inhibitors and Effective Antiproliferative Agents' [patent_app_type] => utility [patent_app_number] => 13/003628 [patent_app_country] => US [patent_app_date] => 2009-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12203 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178027.pdf [firstpage_image] =>[orig_patent_app_number] => 13003628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5959526 [patent_doc_number] => 20110183913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'NOVEL LIPID DIPEPTIDE AND GEL' [patent_app_type] => utility [patent_app_number] => 13/056517 [patent_app_country] => US [patent_app_date] => 2009-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20897 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183913.pdf [firstpage_image] =>[orig_patent_app_number] => 13056517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6162843 [patent_doc_number] => 20110160121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'UNACYLATED GHRELIN AND ANALOGS AS THERAPEUTIC AGENTS FOR VASCULAR REMODELING IN DIABETIC PATIENTS AND TREATMENT OF CARDIOVASCULAR DISEASE' [patent_app_type] => utility [patent_app_number] => 12/996244 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 13745 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160121.pdf [firstpage_image] =>[orig_patent_app_number] => 12996244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9074362 [patent_doc_number] => 08551939 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Peptide analogues, particularly for the treatment of chronic pain' [patent_app_type] => utility [patent_app_number] => 12/995606 [patent_app_country] => US [patent_app_date] => 2009-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1197 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12995606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212323 [patent_doc_number] => 20110135623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'Conjugates of a Cholinesterase Moiety and a Polymer' [patent_app_type] => utility [patent_app_number] => 12/991402 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19604 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135623.pdf [firstpage_image] =>[orig_patent_app_number] => 12991402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6195455 [patent_doc_number] => 20110027209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'Compositions Containing Cyclic Peptides And Methods Of Use' [patent_app_type] => utility [patent_app_number] => 12/936761 [patent_app_country] => US [patent_app_date] => 2009-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45673 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027209.pdf [firstpage_image] =>[orig_patent_app_number] => 12936761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6089253 [patent_doc_number] => 20110217750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'Dendrimers and Dendrimer Applications' [patent_app_type] => utility [patent_app_number] => 12/933380 [patent_app_country] => US [patent_app_date] => 2009-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8403 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217750.pdf [firstpage_image] =>[orig_patent_app_number] => 12933380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6560748 [patent_doc_number] => 20100272675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'METHOD OF ADMINISTERING CONJUGATES' [patent_app_type] => utility [patent_app_number] => 12/743191 [patent_app_country] => US [patent_app_date] => 2008-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9560 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272675.pdf [firstpage_image] =>[orig_patent_app_number] => 12743191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6349272 [patent_doc_number] => 20100249023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'ISOFLAVONE FORMULATION' [patent_app_type] => utility [patent_app_number] => 12/677785 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7859 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249023.pdf [firstpage_image] =>[orig_patent_app_number] => 12677785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6535637 [patent_doc_number] => 20100204155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'USE OF THE PEPTIDE SFLLR-OH AND MURAMYL DIPEPTIDE AS THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/677318 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35091 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204155.pdf [firstpage_image] =>[orig_patent_app_number] => 12677318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6223679 [patent_doc_number] => 20100181197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'ISOELECTRIC POINT MARKERS' [patent_app_type] => utility [patent_app_number] => 12/668686 [patent_app_country] => US [patent_app_date] => 2008-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9452 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20100181197.pdf [firstpage_image] =>[orig_patent_app_number] => 12668686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177350 [patent_doc_number] => 20110177998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'BIOACTIVE PEPTIDES AND METHODS OF USING SAME' [patent_app_type] => utility [patent_app_number] => 12/668712 [patent_app_country] => US [patent_app_date] => 2008-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 36479 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177998.pdf [firstpage_image] =>[orig_patent_app_number] => 12668712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6538485 [patent_doc_number] => 20100221749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'THREE-FUNCTIONAL PSEUDO-PEPTIDIC REAGENT, AND USES AND APPLICATIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/668518 [patent_app_country] => US [patent_app_date] => 2008-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16278 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221749.pdf [firstpage_image] =>[orig_patent_app_number] => 12668518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6231547 [patent_doc_number] => 20100184703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'USE OF PEPTIDE DERIVATIVES FOR TREATING PATHOLOGIES RESULTING FROM ISCHEMIA' [patent_app_type] => utility [patent_app_number] => 12/666462 [patent_app_country] => US [patent_app_date] => 2008-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7776 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184703.pdf [firstpage_image] =>[orig_patent_app_number] => 12666462 [rel_patent_id] =>[rel_patent_doc_number] =>)